An approach to longitudinal studies in a community: the Framingham Study.

PubWeight™: 6.29‹?› | Rank: Top 1%

🔗 View Article (PMID 14025561)

Published in Ann N Y Acad Sci on May 22, 1963

Authors

T R DAWBER, W B KANNEL, L P LYELL

Articles citing this

(truncated to the top 100)

2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 10.24

2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 8.90

Lifetime risks of cardiovascular disease. N Engl J Med (2012) 5.95

Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet (2008) 5.89

Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies. Nat Genet (2009) 5.32

Common variants at ten loci influence QT interval duration in the QTGEN Study. Nat Genet (2009) 5.20

The Framingham Heart Study 100K SNP genome-wide association study resource: overview of 17 phenotype working group reports. BMC Med Genet (2007) 5.02

Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study. Hepatology (2010) 3.60

Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national heart, lung, and blood institute. Circulation (2009) 3.55

Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study. Eur Heart J (2009) 3.54

Neck circumference as a novel measure of cardiometabolic risk: the Framingham Heart study. J Clin Endocrinol Metab (2010) 3.39

Beyond missing heritability: prediction of complex traits. PLoS Genet (2011) 3.39

Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005. Circulation (2009) 3.23

Single versus combined blood pressure components and risk for cardiovascular disease: the Framingham Heart Study. Circulation (2008) 3.16

Collaborative meta-analysis: associations of 150 candidate genes with osteoporosis and osteoporotic fracture. Ann Intern Med (2009) 2.80

Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease. Gastroenterology (2008) 2.70

CUBN is a gene locus for albuminuria. J Am Soc Nephrol (2011) 2.70

Long-term trends in myocardial infarction incidence and case fatality in the National Heart, Lung, and Blood Institute's Framingham Heart study. Circulation (2009) 2.63

Analyze multivariate phenotypes in genetic association studies by combining univariate association tests. Genet Epidemiol (2010) 2.19

Visceral and subcutaneous fat quality and cardiometabolic risk. JACC Cardiovasc Imaging (2013) 2.19

Genome-wide association study for coronary artery calcification with follow-up in myocardial infarction. Circulation (2011) 1.96

Genome-wide association studies of serum magnesium, potassium, and sodium concentrations identify six Loci influencing serum magnesium levels. PLoS Genet (2010) 1.91

Beyond repeated-measures analysis of variance: advanced statistical methods for the analysis of longitudinal data in anesthesia research. Reg Anesth Pain Med (2011) 1.84

A genetic risk score is associated with incident cardiovascular disease and coronary artery calcium: the Framingham Heart Study. Circ Cardiovasc Genet (2012) 1.81

Trends in cardiovascular disease risk factors in individuals with and without diabetes mellitus in the Framingham Heart Study. Circulation (2009) 1.77

Colloquium papers: Natural selection in a contemporary human population. Proc Natl Acad Sci U S A (2009) 1.73

The MYH9/APOL1 region and chronic kidney disease in European-Americans. Hum Mol Genet (2011) 1.71

Pericardial fat is associated with prevalent atrial fibrillation: the Framingham Heart Study. Circ Arrhythm Electrophysiol (2010) 1.70

A meta-analysis of four genome-wide association studies of survival to age 90 years or older: the Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium. J Gerontol A Biol Sci Med Sci (2010) 1.65

Pericardial fat, intrathoracic fat, and measures of left ventricular structure and function: the Framingham Heart Study. Circulation (2009) 1.65

Peri-aortic fat, cardiovascular disease risk factors, and aortic calcification: the Framingham Heart Study. Atherosclerosis (2010) 1.60

Simple area-based measurement for multidetector computed tomography to predict left ventricular size. Eur Radiol (2010) 1.59

Lifetime risk and years lived free of total cardiovascular disease. JAMA (2012) 1.57

Association Between Visceral and Subcutaneous Adipose Depots and Incident Cardiovascular Disease Risk Factors. Circulation (2015) 1.57

Chronic kidney disease as a predictor of cardiovascular disease (from the Framingham Heart Study). Am J Cardiol (2008) 1.56

VASCULAR DISEASE OF THE BRAIN--EPIDEMIOLOGIC ASPECTS: THE FARMINGHAM STUDY. Am J Public Health Nations Health (1965) 1.56

Discriminating clinical features of heart failure with preserved vs. reduced ejection fraction in the community. Eur Heart J (2012) 1.53

Association of Serum Lipids and Coronary Heart Disease in Contemporary Observational Studies. Circulation (2015) 1.51

Relations of lipid concentrations to heart failure incidence: the Framingham Heart Study. Circulation (2009) 1.51

Non-response to baseline, non-response to follow-up and mortality in the Whitehall II cohort. Int J Epidemiol (2009) 1.51

Genomic prediction of coronary heart disease. Eur Heart J (2016) 1.49

Association between single-slice measurements of visceral and abdominal subcutaneous adipose tissue with volumetric measurements: the Framingham Heart Study. Int J Obes (Lond) (2010) 1.49

Axial area and anteroposterior diameter as estimates of left atrial size using computed tomography of the chest: comparison with 3-dimensional volume. J Cardiovasc Comput Tomogr (2009) 1.47

Long-Term Risk of Atherosclerotic Cardiovascular Disease in US Adults With the Familial Hypercholesterolemia Phenotype. Circulation (2016) 1.47

Relation of platelet and leukocyte inflammatory transcripts to body mass index in the Framingham heart study. Circulation (2010) 1.47

Genomewide linkage analysis for internal carotid artery intimal medial thickness: evidence for linkage to chromosome 12. Am J Hum Genet (2004) 1.45

Exclusion and inclusion of nonwhite ethnic minority groups in 72 North American and European cardiovascular cohort studies. PLoS Med (2006) 1.42

Association of novel genetic Loci with circulating fibrinogen levels: a genome-wide association study in 6 population-based cohorts. Circ Cardiovasc Genet (2009) 1.41

Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction. Circ Heart Fail (2012) 1.35

Association of lifestyle factors with abdominal subcutaneous and visceral adiposity: the Framingham Heart Study. Diabetes Care (2008) 1.31

Prevalence, distribution, and risk factor correlates of high pericardial and intrathoracic fat depots in the Framingham heart study. Circ Cardiovasc Imaging (2010) 1.25

Insights on aging and exceptional longevity from longitudinal data: novel findings from the Framingham Heart Study. Age (Dordr) (2006) 1.24

The Framingham Heart Study, on its way to becoming the gold standard for Cardiovascular Genetic Epidemiology? BMC Med Genet (2007) 1.24

Novel measurements of periaortic adipose tissue in comparison to anthropometric measures of obesity, and abdominal adipose tissue. Int J Obes (Lond) (2009) 1.23

CLIA-tested genetic variants on commercial SNP arrays: potential for incidental findings in genome-wide association studies. Genet Med (2010) 1.21

Impact of blood pressure and blood pressure change during middle age on the remaining lifetime risk for cardiovascular disease: the cardiovascular lifetime risk pooling project. Circulation (2011) 1.20

Cumulative deficits and physiological indices as predictors of mortality and long life. J Gerontol A Biol Sci Med Sci (2008) 1.20

A comprehensive genetic approach for improving prediction of skin cancer risk in humans. Genetics (2012) 1.20

Relation of smoking status to a panel of inflammatory markers: the framingham offspring. Atherosclerosis (2008) 1.20

Relation of subcutaneous and visceral adipose tissue to coronary and abdominal aortic calcium (from the Framingham Heart Study). Am J Cardiol (2009) 1.17

Genome-wide association study for serum urate concentrations and gout among African Americans identifies genomic risk loci and a novel URAT1 loss-of-function allele. Hum Mol Genet (2011) 1.13

Temporal trends in self-reported functional limitations and physical disability among the community-dwelling elderly population: the Framingham heart study. Am J Public Health (2008) 1.12

A systematic assessment of causes of death after heart failure onset in the community: impact of age at death, time period, and left ventricular systolic dysfunction. Circ Heart Fail (2010) 1.11

Cardiovascular risk estimation in 2012: lessons learned and applicability to the HIV population. J Infect Dis (2012) 1.09

Nocturia, sleep-disordered breathing, and cardiovascular morbidity in a community-based cohort. PLoS One (2012) 1.07

Gout and the risk for incident heart failure and systolic dysfunction. BMJ Open (2012) 1.06

QT interval and long-term mortality risk in the Framingham Heart Study. Ann Noninvasive Electrocardiol (2012) 1.04

Long-term cardiovascular risks associated with an elevated heart rate: the Framingham Heart Study. J Am Heart Assoc (2014) 1.03

Common genetic variation in multiple metabolic pathways influences susceptibility to low HDL-cholesterol and coronary heart disease. J Lipid Res (2010) 1.03

Intramuscular fat and associations with metabolic risk factors in the Framingham Heart Study. Arterioscler Thromb Vasc Biol (2013) 1.02

Runs of homozygosity identify a recessive locus 12q21.31 for human adult height. J Clin Endocrinol Metab (2010) 1.00

Cardiovascular Disease Risk Assessment: Insights from Framingham. Glob Heart (2013) 0.98

Vitamin E supplement use and the incidence of cardiovascular disease and all-cause mortality in the Framingham Heart Study: Does the underlying health status play a role? Atherosclerosis (2008) 0.97

Eligibility of individuals with subclinical coronary artery calcium and intermediate coronary heart disease risk for reclassification (from the Framingham Heart Study). Am J Cardiol (2009) 0.97

Large common deletions associate with mortality at old age. Hum Mol Genet (2011) 0.96

Sex-specific health deterioration and mortality: the morbidity-mortality paradox over age and time. Exp Gerontol (2008) 0.96

Indexes of kidney function and coronary artery and abdominal aortic calcium (from the Framingham Offspring Study). Am J Cardiol (2008) 0.96

Distribution, determinants, and normal reference values of thoracic and abdominal aortic diameters by computed tomography (from the Framingham Heart Study). Am J Cardiol (2013) 0.96

Evaluating the evidence for transmission distortion in human pedigrees. Genetics (2012) 0.96

Periaortic adipose tissue and aortic dimensions in the Framingham Heart Study. J Am Heart Assoc (2012) 0.95

Clinical correlates and heritability of cystatin C (from the Framingham Offspring Study). Am J Cardiol (2008) 0.94

Genetic associations with expression for genes implicated in GWAS studies for atherosclerotic cardiovascular disease and blood phenotypes. Hum Mol Genet (2013) 0.93

New cholesterol guidelines: worth the wait? Cleve Clin J Med (2014) 0.93

Genome-wide meta-analysis of homocysteine and methionine metabolism identifies five one carbon metabolism loci and a novel association of ALDH1L1 with ischemic stroke. PLoS Genet (2014) 0.93

Hyperuricemia and incident heart failure. Circ Heart Fail (2009) 0.92

Coronary heart disease risks associated with high levels of HDL cholesterol. J Am Heart Assoc (2014) 0.92

Association of fat density with subclinical atherosclerosis. J Am Heart Assoc (2014) 0.90

Hepatic steatosis and cardiovascular disease outcomes: An analysis of the Framingham Heart Study. J Hepatol (2015) 0.90

The Association Between Subcutaneous Fat Density and the Propensity to Store Fat Viscerally. J Clin Endocrinol Metab (2015) 0.89

Association of estimated glomerular filtration rate and urinary uromodulin concentrations with rare variants identified by UMOD gene region sequencing. PLoS One (2012) 0.89

Renal artery calcium, cardiovascular risk factors, and indexes of renal function. Am J Cardiol (2013) 0.89

Early-adulthood cardiovascular disease risk factor profiles among individuals with and without diabetes in the Framingham Heart Study. Diabetes Care (2013) 0.88

Changes in health status among participants of the Framingham Heart Study from the 1960s to the 1990s: application of an index of cumulative deficits. Ann Epidemiol (2008) 0.87

Breastfeeding in infancy and adult cardiovascular disease risk factors. Am J Med (2009) 0.87

HMGA2 is confirmed to be associated with human adult height. Ann Hum Genet (2009) 0.87

Sensitivity and specificity of recalled vasomotor symptoms in a multiethnic cohort. Am J Epidemiol (2008) 0.86

Using family-based imputation in genome-wide association studies with large complex pedigrees: the Framingham Heart Study. PLoS One (2012) 0.86

Real-life evaluation of European and American high-risk strategies for primary prevention of cardiovascular disease in patients with first myocardial infarction. BMJ Open (2014) 0.85

Whole blood gene expression and interleukin-6 levels. Genomics (2014) 0.84

Metabolic characterization of adults with binge eating in the general population: the Framingham Heart Study. Obesity (Silver Spring) (2014) 0.83

Articles by these authors

Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health Nations Health (1951) 20.27

Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study. Ann Intern Med (1961) 12.08

Coronary heart disease in the Framingham study. Am J Public Health Nations Health (1957) 4.13

Some factors associated with the development of coronary heart disease: six years' follow-up experience in the Framingham study. Am J Public Health Nations Health (1959) 3.48

RISK FACTORS IN CORONARY HEART DISEASE. AN EVALUATION OF SEVERAL SERUM LIPIDS AS PREDICTORS OF CORONARY HEART DISEASE; THE FRAMINGHAM STUDY. Ann Intern Med (1964) 3.06

THE RELATIONSHIP OF CIGARETTE SMOKING TO CORONARY HEART DISEASE; THE SECOND REPORT OF THE COMBINED EXPERIENCE OF THE ALBANY, NY. AND FRAMINGHAM, MASS. STUDIES. JAMA (1964) 2.90

Cigarette smoking and coronary heart disease. Combined experience of the Albany and Framingham studies. N Engl J Med (1962) 2.62

The epidemiology of coronary heart disease--the Framingham enquiry. Proc R Soc Med (1962) 2.55

THE ELECTROCARDIOGRAM IN EPIDEMIOLOGICAL STUDIES: REPRODUCIBILITY, VALIDITY, AND INTERNATIONAL COMPARISON. Br J Prev Soc Med (1965) 2.48

The effects of the absorption of fluoride. II. A radiological investigation of five hundred and forty-six human residents of an area in which the drinking water contained only a minute trace of fluoride. AMA Arch Ind Health (1960) 1.82

Susceptibility to coronary heart disease. Mod Concepts Cardiovasc Dis (1961) 1.64

VASCULAR DISEASE OF THE BRAIN--EPIDEMIOLOGIC ASPECTS: THE FARMINGHAM STUDY. Am J Public Health Nations Health (1965) 1.56

THE CORONARY PROFILE. Ann N Y Acad Sci (1963) 1.50

OCCLUSION OF PERIPHERAL ARTERIES: A STUDY OF 6,400 WORKING SUBJECTS. Circulation (1964) 1.43

The Framingham study: a prospective study of coronary heart disease. Fed Proc (1962) 1.29

Human serum lipoprotein concentrations. J Gerontol (1954) 1.27

Epidemiology of coronary heart disease. Implications for the practicing physician. Geriatrics (1962) 1.26

Atherosclerosis and you: pathogentic implications from epidemiologic observations. J Am Geriatr Soc (1962) 1.13

The silent coronary: the frequency and clinical characteristics of unrecognized myocardial infarction in the Framingham study. Ann Intern Med (1959) 1.12

An epidemiologic study of heart disease: the Framingham study. Nutr Rev (1958) 1.06

Dietary assessment in the epidemiologic study of coronary heart disease: the Framingham study. II. Reliability of measurement. Am J Clin Nutr (1962) 1.04

The electrocardiogram in heart disease detection; a comparison of the multiple and single lead procedures. Circulation (1952) 1.02

Diet and cardiovascular disease in the Framingham study. I. Measurement of dietary intake. Am J Clin Nutr (1962) 1.02

Significance of solitary nontoxic thyroid nodules; preliminary report. N Engl J Med (1954) 1.00

The electrocardiogram in neurocirculatory asthenia (anxiety, neurosis or asthenia patients and 757 healthy controls in the Framingham study. Ann Intern Med (1958) 1.00

Rheumatic heart disease in the Framingham study. N Engl J Med (1956) 0.95

THE PREDICTION OF CORONARY HEART DISEASE. Trans Assoc Life Insur Med Dir Am (1964) 0.92

Computers in epidemiologic research. Uses in the Framingham study. Circ Res (1962) 0.90

The use of computers in cardiovascular epidemiology. Prog Cardiovasc Dis (1963) 0.87

Summary of recent literature regarding cigarette smoking and coronary heart disease. Circulation (1960) 0.86

[HAZARDS OF CORONARY DISEASE. CONCLUSIONS FOR MEDICAL PRACTICE FROM 10 YEARS OF FRAMINGHAM STUDY]. Schweiz Med Wochenschr (1965) 0.77

COMPARISON OF SERUM LIPIDS IN THE PREDICTION OF CORONARY HEART DISEASE. FRAMINGHAM STUDY INDICATES THAT CHOLESTEROL LEVEL AND BLOOD PRESSURE ARE MAJOR FACTORS IN CORONARY HEART DISEASE; EFFECT OF OBESITY AND CIGARETTE SMOKING ALSO NOTED. R I Med J (1965) 0.77

Coronary heart disease as an epidemiology entity. Am J Public Health Nations Health (1963) 0.75

Pulmonary function in a community sample. Am Rev Respir Dis (1962) 0.75